Antibiotic for Oral Suspension Pulled
Lupin Pharmaceuticals Inc. is recalling 7215 bottles of cephalexin for oral suspension USP, 250 mg/5 mL, 200 mL (when mixed) (NDC 68180-0124-02). According to the January 23, 2019, US Food and Drug Administration (FDA) Enforcement Report, the recall stems from Current Good Manufacturing Practice regulation deviations. Specifically, the manufacturing batch record was lost.
The recall spans bottles from lot F602820 (Exp. 12/19). The bottles were sent to 12 major distributors, who may have further distributed the product throughout the United States.
Lupin Pharmaceuticals voluntarily initiated the recall January 7, 2019. On January 16, 2019, the
FDA designated it Class II. Under Class II recalls, use of the product could cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm.
Cephalexin for oral suspension is a prescription antibiotic used to treat a range of bacterial infections.
—Jolynn Tumolo
For more Pharmacy Learning Network articles, visit the homepage


